Evidence map›Paper›PMID 35814800›Full record

ArticleCase reports in gastroenterology

Acute Liver Failure after Treatment with Rivaroxaban for Aortic Thrombosis Associated with COVID-19 Infection and Methylenetetrahydrofolate Reductase Gene Polymorphism (C677T).

Ivana Jukic, Dorotea Bozic, Milos Lalovac, Mirela Pavicic Ivelja, Mislav Radic, Zeljko Sundov, Jonatan Vukovic

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ivana JukicDepartment of Gastroenterology and Hepatology, University Hospital of Split, Split, Croatia.
Dorotea BozicDepartment of Gastroenterology and Hepatology, University Hospital of Split, Split, Croatia.
Milos LalovacDepartment of Gastroenterology and Hepatology, Merkur University Hospital, Zagreb, Croatia.
Mirela Pavicic IveljaDepartment of Infectious Diseases, University Hospital of Split, Split, Croatia.
Mislav RadicDivision of Clinical Immunology and Rheumatology, Department of Internal Medicine, University Hospital of Split, Split, Croatia.
Zeljko SundovDepartment of Gastroenterology and Hepatology, University Hospital of Split, Split, Croatia.
Jonatan VukovicDepartment of Gastroenterology and Hepatology, University Hospital of Split, Split, Croatia.
University of Split · HRKlinička bolnica Merkur · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease-2019 (COVID-19) has become associated with prothrombotic state that could lead to severe arterial thrombotic complications. In the case of severe COVID-19 infection, hepatic dysfunction has been observed in more than 50% of patients. In this article, we present a case of aortic thrombosis associated with COVID-19 infection and methylenetetrahydrofolate reductase gene polymorphism (C677T) treated with rivaroxaban resulting in acute liver failure with fatal outcome.

Indexed as

Acute liver failureArterial thrombosisCOVID-19RivaroxabanThrombophilia

Identifiers

PMID35814800
PMCPMC9209999
OpenAlexW4281398822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.